DNA vaccine expresses HPV16 E6/E7/L2 and enhances MHC I presentation, inducing E6-specific CD8+ T cells that recognize E6 peptides on target cells and kill them via perforin/granzyme-mediated cytotoxicity (with CD4+ T-cell help).